Skip to main content

The AHLA and ABA Health Law Section/Section of Antitrust Law jointly hosted this year's two-day Antitrust in Healthcare program in Arlington, Virginia on 13-14 May. The program brought together an expert faculty made up of the leading government enforcers, private counsel representing both plaintiffs and defendants, and forensic and academic economists to share their insights and offer practical advice and policy recommendations.

NERA President Dr. Lawrence Wu and Senior Consultant Dr. Subramaniam Ramanarayanan were invited to participate in the program. On the second day, Dr. Wu took part in a panel session entitled "Assessing Market Power and Harm to Competition in Evolving Healthcare Markets." The session addressed the challenges in assessing market power and harm to competition in evolving healthcare markets, as well as the complex legal and economic issues that often arise when evaluating the competitive impact of various types of transactions and vertical contractual relationships that are becoming more prevalent as healthcare markets evolve. Also that day, Dr. Ramanarayanan joined a panel session entitled "New Concepts and Empirical Tools in Healthcare Transactions." The panelists examined the underlying theory and applications of a relatively new set of tools and concepts used in the analysis of healthcare transactions, including bargaining theory, merger simulation models, diversion ratios, and value-based contracting.